Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.
Identifieur interne : 00B070 ( Main/Exploration ); précédent : 00B069; suivant : 00B071Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.
Auteurs : R K Shenoy [Inde] ; T K Suma ; K. Rajan ; V. KumaraswamiSource :
- Annals of tropical medicine and parasitology [ 0003-4983 ] ; 1998.
Descripteurs français
- KwdFr :
- Adulte, Animaux, Antihelminthiques antinématodes (administration et posologie), Brugia malayi, Diéthylcarbamazine (administration et posologie), Femelle, Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Humains, Ivermectine (administration et posologie), Lymphangite (), Maladie aigüe, Mâle, Méthode en double aveugle.
- MESH :
- administration et posologie : Antihelminthiques antinématodes, Diéthylcarbamazine, Ivermectine.
- traitement médicamenteux : Filariose lymphatique.
- Adulte, Animaux, Brugia malayi, Femelle, Filariose lymphatique, Humains, Lymphangite, Maladie aigüe, Mâle, Méthode en double aveugle.
English descriptors
- KwdEn :
- Acute Disease, Adult, Animals, Antinematodal Agents (administration & dosage), Brugia malayi, Diethylcarbamazine (administration & dosage), Double-Blind Method, Elephantiasis, Filarial (complications), Elephantiasis, Filarial (drug therapy), Female, Humans, Ivermectin (administration & dosage), Lymphangitis (prevention & control), Male.
- MESH :
- chemical , administration & dosage : Antinematodal Agents, Diethylcarbamazine, Ivermectin.
- complications : Elephantiasis, Filarial.
- drug therapy : Elephantiasis, Filarial.
- prevention & control : Lymphangitis.
- Acute Disease, Adult, Animals, Brugia malayi, Double-Blind Method, Female, Humans, Male.
Abstract
Acute attacks of adenolymphangitis (ADL) not only force patients with lymphatic filariasis to seek medical attention but also hasten the progression of filarial oedema. Patients with filariasis-associated ADL are currently treated with repeated courses of the antifilarial drug diethylcarbamazine (DEC), with or without antibiotics and anti-inflammatory agents. In this double-blind, placebo-controlled study, the efficacy of local treatment of the affected limb combined with repeated doses of ivermectin or DEC, in preventing the occurrence of ADL in Brugia malayi lymphatic filariasis, was examined. Overall, 120 patients who had each had at least two ADL attacks in the previous year were each admitted to the study at the time of an ongoing episode of ADL. The patients were randomly allocated to receive 12, monthly treatments of ivermectin (400 micrograms/kg), DEC (10 mg/kg) or placebo, in addition to local care of the affected limbs. There was a significant reduction in the frequency of ADL attacks in each of the three groups during the 2-year study period (P < 0.001 for each comparison). Most importantly, there were no significant differences in frequency of attacks between the three groups, either at the end of the treatment phase or at the end of the post-treatment phase (P > 0.15 for each comparison), suggesting that foot care combined with appropriate use of local antibiotics or antifungals is adequate to reduce the number of ADL attacks. The implications of these observations for planning morbidity control in lymphatic filariasis are discussed.
PubMed: 9797832
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004E06
- to stream PubMed, to step Curation: 004E06
- to stream PubMed, to step Checkpoint: 004E06
- to stream Ncbi, to step Merge: 00BD07
- to stream Ncbi, to step Curation: 00BD07
- to stream Ncbi, to step Checkpoint: 00BD07
- to stream Main, to step Merge: 00B730
- to stream Main, to step Curation: 00B070
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.</title><author><name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name><affiliation wicri:level="1"><nlm:affiliation>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alleppey, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alleppey</wicri:regionArea><wicri:noRegion>Alleppey</wicri:noRegion></affiliation></author><author><name sortKey="Suma, T K" sort="Suma, T K" uniqKey="Suma T" first="T K" last="Suma">T K Suma</name></author><author><name sortKey="Rajan, K" sort="Rajan, K" uniqKey="Rajan K" first="K" last="Rajan">K. Rajan</name></author><author><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1998">1998</date><idno type="RBID">pubmed:9797832</idno><idno type="pmid">9797832</idno><idno type="wicri:Area/PubMed/Corpus">004E06</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004E06</idno><idno type="wicri:Area/PubMed/Curation">004E06</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004E06</idno><idno type="wicri:Area/PubMed/Checkpoint">004E06</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004E06</idno><idno type="wicri:Area/Ncbi/Merge">00BD07</idno><idno type="wicri:Area/Ncbi/Curation">00BD07</idno><idno type="wicri:Area/Ncbi/Checkpoint">00BD07</idno><idno type="wicri:doubleKey">0003-4983:1998:Shenoy R:prevention:of:acute</idno><idno type="wicri:Area/Main/Merge">00B730</idno><idno type="wicri:Area/Main/Curation">00B070</idno><idno type="wicri:Area/Main/Exploration">00B070</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.</title><author><name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name><affiliation wicri:level="1"><nlm:affiliation>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alleppey, India.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Filariasis Chemotherapy Unit, T.D. Medical College Hospital, Alleppey</wicri:regionArea><wicri:noRegion>Alleppey</wicri:noRegion></affiliation></author><author><name sortKey="Suma, T K" sort="Suma, T K" uniqKey="Suma T" first="T K" last="Suma">T K Suma</name></author><author><name sortKey="Rajan, K" sort="Rajan, K" uniqKey="Rajan K" first="K" last="Rajan">K. Rajan</name></author><author><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name></author></analytic><series><title level="j">Annals of tropical medicine and parasitology</title><idno type="ISSN">0003-4983</idno><imprint><date when="1998" type="published">1998</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease</term><term>Adult</term><term>Animals</term><term>Antinematodal Agents (administration & dosage)</term><term>Brugia malayi</term><term>Diethylcarbamazine (administration & dosage)</term><term>Double-Blind Method</term><term>Elephantiasis, Filarial (complications)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Female</term><term>Humans</term><term>Ivermectin (administration & dosage)</term><term>Lymphangitis (prevention & control)</term><term>Male</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Animaux</term><term>Antihelminthiques antinématodes (administration et posologie)</term><term>Brugia malayi</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Femelle</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Humains</term><term>Ivermectine (administration et posologie)</term><term>Lymphangite ()</term><term>Maladie aigüe</term><term>Mâle</term><term>Méthode en double aveugle</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antinematodal Agents</term><term>Diethylcarbamazine</term><term>Ivermectin</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antihelminthiques antinématodes</term><term>Diéthylcarbamazine</term><term>Ivermectine</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphangitis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term><term>Adult</term><term>Animals</term><term>Brugia malayi</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Male</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Animaux</term><term>Brugia malayi</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Lymphangite</term><term>Maladie aigüe</term><term>Mâle</term><term>Méthode en double aveugle</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Acute attacks of adenolymphangitis (ADL) not only force patients with lymphatic filariasis to seek medical attention but also hasten the progression of filarial oedema. Patients with filariasis-associated ADL are currently treated with repeated courses of the antifilarial drug diethylcarbamazine (DEC), with or without antibiotics and anti-inflammatory agents. In this double-blind, placebo-controlled study, the efficacy of local treatment of the affected limb combined with repeated doses of ivermectin or DEC, in preventing the occurrence of ADL in Brugia malayi lymphatic filariasis, was examined. Overall, 120 patients who had each had at least two ADL attacks in the previous year were each admitted to the study at the time of an ongoing episode of ADL. The patients were randomly allocated to receive 12, monthly treatments of ivermectin (400 micrograms/kg), DEC (10 mg/kg) or placebo, in addition to local care of the affected limbs. There was a significant reduction in the frequency of ADL attacks in each of the three groups during the 2-year study period (P < 0.001 for each comparison). Most importantly, there were no significant differences in frequency of attacks between the three groups, either at the end of the treatment phase or at the end of the post-treatment phase (P > 0.15 for each comparison), suggesting that foot care combined with appropriate use of local antibiotics or antifungals is adequate to reduce the number of ADL attacks. The implications of these observations for planning morbidity control in lymphatic filariasis are discussed.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><noCountry><name sortKey="Kumaraswami, V" sort="Kumaraswami, V" uniqKey="Kumaraswami V" first="V" last="Kumaraswami">V. Kumaraswami</name><name sortKey="Rajan, K" sort="Rajan, K" uniqKey="Rajan K" first="K" last="Rajan">K. Rajan</name><name sortKey="Suma, T K" sort="Suma, T K" uniqKey="Suma T" first="T K" last="Suma">T K Suma</name></noCountry><country name="Inde"><noRegion><name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B070 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00B070 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:9797832
|texte= Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:9797832" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |